Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Interactive Tools
Sponsored
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Inside the Clinic: Global Insights: Multidisciplinary Care of Stage III NSCLC
EP. 1: The Multidisciplinary Care of Stage III NSCLC
May 2nd 2019
EP. 2: Overview of Molecular Testing in Stage III NSCLC
May 2nd 2019
EP. 3: Tissue Collection: In-House Sampling and Reflex Testing
May 2nd 2019
EP. 4: Ensuring Reliable Results From Molecular Testing
May 2nd 2019
EP. 5: Assay Validation and Interdisciplinary Communication
May 2nd 2019
EP. 6: Immunotherapy in Stage III NSCLC
May 2nd 2019
EP. 7: How Durvalumab Has Changed the Standard of Care
May 2nd 2019
EP. 8: Impact of the PACIFIC Study Updated Analysis
May 2nd 2019
EP. 9: Importance of PD-L1 Status in Treating Stage III NSCLC
May 2nd 2019
EP. 10: Recommended Settings for Durvalumab Treatment
May 2nd 2019
NEXT PAGE
<
1
2
>
PREVIOUS PAGE